Prospects for prevention and treatment of cancer with selective PPARgamma modulators (SPARMs). (Q34351445)

1 August 2017

1 reference

title

Prospects for prevention and treatment of cancer with selective PPARgamma modulators (SPARMs). (English)

1 reference

1 August 2017

1 reference

Sporn MB

1

1 reference

1 August 2017

Suh N

series ordinal

2

1 reference

1 August 2017

Mangelsdorf DJ

series ordinal

3

1 reference

1 August 2017

publication date

1 September 2001

1 reference

Trends in Molecular Medicine

1 August 2017

published in

1 reference

1 August 2017

volume

7

1 reference

1 August 2017

issue

9

1 reference

1 August 2017

page(s)

395-400

1 reference

Chemoprevention of cancer

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Tamoxifen, raloxifene, and the prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

The nuclear receptor superfamily: the second decade

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

The RXR heterodimers and orphan receptors

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

The PPARs: from orphan receptors to drug discovery

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

1 reference

7 January 2021

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Selective oestrogen receptor modulation: molecular pharmacology for the millennium

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

The Molecular Pharmacology of SERMs

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

PPAR gamma and the treatment of insulin resistance

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Activation of specific RXR heterodimers by an antagonist of RXR homodimers

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

1 reference

7 January 2021

Role of transforming growth factor-beta signaling in cancer

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/ mice

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Terminal differentiation of human breast cancer through PPAR gamma

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Transcriptional control. Sinful repression

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Increasing the complexity of coactivation in nuclear receptor signaling

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Discrete roles for peroxisome proliferator-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

TGFbeta signaling in growth control, cancer, and heritable disorders

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Role of the histone deacetylase complex in acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Retinoids and demethylating agents- looking for partners

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer.

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Atherosclerosis. the road ahead

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

The hormone resistin links obesity to diabetes

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN.

1 reference

https://api.crossref.org/works/10.1016/S1471-4914(01)02100-1

7 January 2021

10.1016/S1471-4914(01)02100-1

Identifiers

DOI

1 reference

1 August 2017

1 reference